Hecate-EGH Lender Litigation Settled; Business Combination Slips to Early Q1 2027
EGHA is trading near its 52-week low of $9.314 (12% above the low).
Summary
EGH and Hecate settled the lender litigation that had stalled their $1.2B business combination, but closing is now pushed to early Q1 2027 and Hecate is pursuing interim capital.
Key Events · M&A and Partnerships · EGHA
-
Lender Litigation Settled
Parties entered a mutual release and settlement agreement on August 27, 2026, and intend to file a motion to dismiss the Delaware Chancery Court suit.
-
Closing Timeline Delayed
Business combination now expected to close in early Q1 2027, versus the prior Q4 2026 expectation stated in the Q2 10-Q.
-
Interim Capital Discussions
Hecate is in discussions with potential interim investors for additional capital to support the de-SPAC process and strengthen its balance sheet.
-
Deal Terms Unchanged
Pre-money enterprise value remains approximately $1.2 billion, with Hecate to list on Nasdaq under ticker HCTE.
Analysis · EGHA · Real Estate & Construction
The lender-related litigation that had delayed the Hecate business combination is now settled, with a motion to dismiss expected. However, the closing timeline has slipped from Q4 2026 to early Q1 2027, and Hecate is seeking interim capital to strengthen its balance sheet before the de-SPAC completes. The resolution removes a major overhang, but the delay and need for bridge financing show the deal still faces execution hurdles.
How filings like this one have moved
In the 30 days to Sep 10, 2026, 30.1% of the 2014 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.11%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, EGHA was trading at $10.40 on NASDAQ in the Real Estate & Construction sector, with a market capitalization of approximately $213.2M. The 52-week trading range was $9.31 to $10.80. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.